On August 1 2023, CARDLYTICS ($NASDAQ:CDLX) reported its second quarter of FY2023 earnings results, which ended June 30 2023. The company’s total revenue for the quarter was USD 76.7 million, representing a 1.7% increase from the same quarter in the prior year. Additionally, CARDLYTICS’ net income for the quarter was USD -23.5 million, compared to a net loss of USD 126.3 million the prior year.
On Tuesday, CARDLYTICS released their financial results for the second quarter of the fiscal year 2023, ending on June 30, 2023. The stock opened at $11.6 and ultimately closed at $11.3, down by 3.4% from the previous closing price of 11.7. The news of the earnings report resulted in a downward trend for CARDLYTICS stock. Investors and analysts are watching closely to see how the company performs in the coming months and how the stock reacts to it.
Overall, the earnings report was in line with expectations but investors are looking forward to seeing more positive results from CARDLYTICS in the coming quarters. The company has plans to reduce costs further and focus on growing its core business, which should help it turn a profit in the near future. Live Quote…
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Cardlytics. CARDLYTICS_Reports_Q2_FY2023_Earnings_Results_for_Period_Ending_June_30_2023″>More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cardlytics. CARDLYTICS_Reports_Q2_FY2023_Earnings_Results_for_Period_Ending_June_30_2023″>More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cardlytics. CARDLYTICS_Reports_Q2_FY2023_Earnings_Results_for_Period_Ending_June_30_2023″>More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Cardlytics are shown below. CARDLYTICS_Reports_Q2_FY2023_Earnings_Results_for_Period_Ending_June_30_2023″>More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
GoodWhale is here to provide you with an in-depth financial analysis of CARDLYTICS so that you can make an informed decision when it comes to investing. Our Risk Rating system shows that CARDLYTICS is a high risk investment. To better understand the reasoning behind this, our team has identified four potential risks associated with the company’s income sheet, balance sheet, cashflow statement, and financial journal. As a GoodWhale user, you will have access to this information and more so that you can make the best decision possible. More…
Risk Rating Analysis
Star Chart Analysis
The company has offices in the United States, United Kingdom, and Germany. Cardlytics Inc’s competitors include Affle India Ltd, Propel Media Inc, and Engage:BDR Ltd.
Affle India Ltd is a technology company that provides consumer insights, engagement, and monetization platforms. The company operates in two segments, Consumer Platform and Enterprise Platform. It offers consumer insights and engagement solutions, such as Appointments, which allows users to schedule appointments with businesses; Deals, which provides users with personalized deals and offers; and Rewards, which allows users to earn rewards for completing tasks. The company also offers an enterprise platform that enables businesses to connect with their customers and employees.
Propel Media Inc is a publicly traded digital media company that operates a number of online properties, including the video sharing website Vimeo. The company was founded in 2004 and is headquartered in New York City. As of 2022, Propel Media had a market capitalization of $19.98 million and a negative return on equity of 67.1%. The company’s primary business is operating Vimeo, which allows users to upload, share, and view videos. The site has over 100 million registered users and generates revenue through advertisements and paid memberships.
CARDLYTICS reported its earnings results for the second quarter of FY2023, ending June 30 2023, on August 1 2023. Total revenue for the quarter was USD 76.7 million, representing a 1.7% increase from the same period last year. Net income was USD -23.5 million, compared to a net loss of USD 126.3 million in the previous year.
Despite these performance improvements, the stock price reacted negatively, suggesting that investors felt the results were not sufficient to merit positive sentiment. Investors should continue to monitor CARDLYTICS’ performance going forward and may want to consider adjusting their positions in light of the latest earnings report.